Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Address: 1801 Research Boulevard, Suite 400 Rockville, Maryland 20850 Phone: 301.984.9496 | Fax: 301.770.1949 Amy Lydic, CAE Executive Director Limaya Atembina, MSW Senior Manager, Oncology State Societies Membership
media_ACCC_hospital_survey072407
Address: 1801 Research Boulevard, Suite 400 Rockville, Maryland 20850 Phone: 301.984.9496 | Fax: 301.770.1949 Brandon Lawrence Executive Director Limaya Atembina, MSW Senior Manager, Oncology State Societies Membership
Mission Statement To be the leading education and advocacy organization for the cancer care community. Core Values ACCC will fulfill its core purpose by pursuing and adhering to these core values: Integrity - Collaboration - Stewardship - Knowledge - Service - Innovation - Excellence - Compassion Strategic Objectives Ideal Future State: ACCC is a leader in the cancer care …
Who Are We? Founded in 1992, the Louisiana Oncology Society (LOS) is the largest oncology professional organization in the state. LOS comprises a powerful community of oncologists, nurse practitioners, physician assistants, pharmacists, and other multidisciplinary care providers involved in the treatment of patients with cancer. LOS is one of 23 State Chapter Members managed by the Association of Cancer …
Who Are We? Founded in 1991, the Rocky Mountain Oncology Society (RMOS) is the largest oncology professional organization in the state. RMOS comprises a powerful community of oncologists, nurse practitioners, physician assistants, pharmacists, and other multidisciplinary care providers involved in the treatment of patients with cancer. RMOS is one of 23 State Chapter Members managed by the Association …
MJ13-The-Story-Behind-the-Dream-Hat
New Mexico Oncology Hematology Consultants, Ltd. Albuquerque, New Mexico COME HOME—A Model Oncology Medical Home NMHO's COME HOME medical home model, now being piloted in seven independent practices, is expected to deliver a cost-savings of more than $33 million in just three years. Learn the six tenets of this model program, how to educate staff and recruit volunteers, and strategies to leverage …
ACCC is devoted to providing up-to-date resources and education to help improve patient care and survival rates for those diagnosed with renal cell carcinoma (also known as kidney cancer).
ACCC offers diverse educational resources, digital tools and publications that address the complex challenges in delivering quality lung cancer care.
Colorectal cancer represents 8.3 percent of all new cancer diagnoses in the U.S. In 2016, there were an estimated 1,324,922 people in the U.S. living with colorectal cancer.
As the use of biomarker testing options in the treatment of certain cancers continues to grow, so too do barriers to their use. Underpinning these barriers is a lack of understanding about how biomarker testing works and what impact it can have on selecting the most promising cancer treatment options. Measurable residual disease (also known as “minimal residual disease”) refers to the number of cancer …
The goal of this initiative is to provide guidance for multidisciplinary care teams on how to develop practical biomarker testing protocols for metastatic colorectal cancer.
ACCC has developed an initiative titled Optimizing Outcomes in Advanced/Metastatic Gastric Cancer to support health care providers in applying evidence-based treatment selection for patients with advanced/metastatic gastric cancer.
About half of all bladder cancers detected each year in the United States are non-invasive, while around one in three spreads to deeper cell layers in the bladder wall.
Chronic lymphocytic leukemia is a cancer of the B-lymphocytes that may be found in bone marrow, blood, lymph nodes, the spleen, and other organs.CLL is the most common form of leukemia in adults and accounts for one quarter of new leukemia cases annually.
ACCC education programs examine the latest multidisciplinary education and resources regarding health disparities in breast cancer care, the latest clinical advances, and initiatives that aim to improve the quality of breast cancer patient care.
Representing a community of more than 28,000 practitioners and 2,100 programs and practices across the United States, ACCC has the unique ability to promote quality care for the treatment of gastrointestinal cancers.
Through education and advocacy, ACCC seeks to improve cancer outcomes for patients diagnosed with adrenal, bladder, kidney (also known as renal), penile, prostate, and testicular cancers.
Attend this free e-course to learn more about clinical trials as a treatment option for patients with blood cancer. Kelly Laschinger, MSN, RN, CPNP, CPHON, manager of the Leukemia & Lymphoma Society’s (LLS’s) Clinical Trial Support Center (CTSC) in Rye Brook, New York, and Steven Tsai, MD, PhD, hematologist at UCLA Health Cancer Care in Los Angeles, California, will discuss the CTSC created by …